MARA Holdings
MARA
Salesforce
CRM
Microsoft
MSFT
Apple
AAPL
Coinbase
COIN
US Stock MarketDetailed Quotes
CTNM Contineum Therapeutics
- 14.000
- -0.250-1.75%
Trading Dec 12 13:38 ET
360.89MMarket Cap-12.47P/E (TTM)
14.265High13.930Low16.72KVolume14.110Open14.250Pre Close235.11KTurnover0.13%Turnover Ratio1272.73P/E (Static)25.78MShares22.00052wk High1.72P/B183.82MFloat Cap12.33052wk Low--Dividend TTM13.13MShs Float22.000Historical High--Div YieldTTM2.35%Amplitude12.330Historical Low14.064Avg Price1Lot Size
About Contineum Therapeutics Company
Contineum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing novel, oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. The company was founded by Daniel S. Lorrain on May 9, 2017 and is headquartered in San Diego, CA.
Company Profile
SymbolCTNM
Company NameContineum Therapeutics
Listing DateApr 5, 2024
Issue Price16.00
Founded2017
CEOMr. Carmine Stengone
MarketNASDAQ
Employees31
Fiscal Year Ends12-31
Address3565 General Atomics Court,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-333-5280
Websitehttp://www.contineum-tx.com
Company Executives
- Name
- Position
- Salary
- Carmine Stengone
- Chief Executive Officer, President and Chairman of the Board
- 2.32M
- Stephen L. Huhn, M.D.
- Chief Medical Officer and Senior Vice President, Clinical Development
- --
- Peter T. Slover
- Chief Financial Officer and Principal Accounting Officer
- 1.03M
- Daniel S. Lorrain, PhD
- Chief Science Officer
- 1.79M
- Sarah Boyce
- Independent Director
- --
- Troy A. Ignelzi
- Independent Director
- --
- Evert B. Schimmelpennink
- Independent Director
- 23.82K
- Dr. Todd C. Brady, M.D.,PhD
- Independent Director
- --
- Olivia C. Ware, M.B.A.
- Independent Director
- --
- Lori Lyons-Williams
- Independent Director
- 25.00K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.